期刊文献+

应用全面质量管理体系运转法降低辅助生殖技术刺激周期中重度卵巢过度刺激综合征发生率 被引量:7

Application of total quality management system methods to reduce the incidence of moderate and severe ovarian hyperstimulation syndrome in assisted reproductive technology cycles
原文传递
导出
摘要 目的探讨应用全面质量管理体系运转法的PDCA循环管理工具是否能降低中重度卵巢过度刺激综合征(OHSS)的发生率。方法 2017年上半年应用PDCA循环法实施一系列干预措施,比较开展PDCA前(2016年1~6月)、后(2017年1~6月)辅助生殖技术(ART)刺激周期患者的临床资料。结果患者平均年龄、体质量指数(BMI)、基础卵泡刺激素(FSH)、基础促黄体生成素(LH)、基础雌二醇(E2)、平均促性腺激素(Gn)使用时间、Gn用量在PDCA开展前、后差异均无统计学意义。开展PDCA后中重度OHSS患者的血抗苗勒管激素(AMH)、基础窦卵泡数、人绒毛膜促性腺激素(h CG)注射日血E2水平明显高于PDCA前(P=0.00、P=0.00、P=0.03)。PDCA后中重度OHSS发生率(1.2%)、新鲜周期胚胎移植率(54.5%)、迟发型OHSS发生率(54.5%)较PDCA前明显下降(2.1%、86.0%、82.5%,P=0.01、P=0.00、P=0.01),PDCA后氯米芬(CC)温和刺激促排卵方案比率(45.5%)、全部胚胎冷冻率(45.5%)明显增加(17.5%、14.0%,P=0.01、P=0.00)。达菲林触发排卵比率、正常受精率、卵裂率较PDCA前无明显增加。结论应用PDCA循环,实施一系列防止中重度OHSS发生的措施,可降低ART刺激周期中重度OHSS发生率。 Objective To explore whether the application of PDCA cycle management tools can reduce the incidence of moderate and severe ovarian hyperstimulation syndrome (OHSS). Methods Based on PDCA cycle management tools, some interventions were performed in patients in assisted reproductive technology (ART) stimulation cycles. The data of the patients were compared before (from January to June 2016) and after (from January to June 2017) PDCA. Results In both groups before and after PDCA cycle, there were no significant differences in patients' age, body mass index (BMI), the level of basal follicle stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2), average duration of gonadotropin (Gn) used, Gn consumption. After PDCA cycle, the incidence of moderate and severe OHSS (1.2%), the embryo transplantation rate (54.5%), the late-onset OHSS rate (54.5%) were significantly reduced compared with before PDCA cycle (2.1%, 86.0%, 82.5%; P=0.01, P=O.O0, P=0.01). After PDCA cycle, the rates of clomiphene citrate (CC) mild-stimulation protocol (45.5%) and all embryos-freezing cycles (45.5%) were significantly increased (17.5%, 14.0%; e=0.01, P=0.00). There were no significant differences in the incidence of severe OHSS, the Diphereline trigger rate, 2 pronucleus (PN) fertilization rate, and cleavage rate. Conclusion With using PDCA management cycle, a series of interventions for prevention OHSS had been done to reduce the incidence of moderate and severe OHSS rates in ART cycles.
作者 黄洁 蔡令波 刁飞扬 马翔 丁卫 柴德春 刘嘉茵 冒韵东 Huang Jie, Cai Lingbo, Diao Feiyang, Ma Xiang, Ding Wei, Chai Dechun, Liu Jiayin, Mao Yundong(Center of Clinical Reproductive Medicine, the First Affiliated Hospital, Nanjing Medical University, Quality Control Center of Reproductive Health and Infertility, Jiangsu Province, Nanjing 210029, Chin)
出处 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2018年第8期616-620,共5页 Chinese Journal of Reproduction and Contraception
关键词 辅助生育技术(ART)卵巢过度刺激综合征(OHSS) PDCA循环 促排卵 并发症 Assisted reproductive technology (ART) Ovarian hyperstimulation syndrome (OHSS) PDCA cycle Ovarian stimulation Complication
  • 相关文献

参考文献1

二级参考文献17

  • 1Kaww~ss JF, Ki'ssin DM, Kulkami AD, et al. Safety of assisted reproductive technology in the United States, 2000-2011. JAMA, 2015, 313(1):88-90.
  • 2Lyons CA, Wheeler CA, Frishman GN, et al. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod, 1994, 9(5):792-9.
  • 3Golan A, Ron-el R, Herman A, et al. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv, 1989, 44(6):430-40.
  • 4Ben-Shlomo I, Geslevich J, Shalev E. Can we abandon routine evaluation of serum estradiol levels during controlled ovarian hyperstimulation for assisted reproduction? Fertil Steril, 2001, 76(2):300-3.
  • 5Tollan A, Hoist N, Forsdahl F, et al. Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization. Am J Obstet Gynecol, 1990, 162(2):554-8.
  • 6Navot D, Relou A, Birkenfeld A, et al. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol, 1988, 159(1):210-5.
  • 7Reljic M, Vlaisavljevic V, Gavric V, et al. Number ofoocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome. J Reprod Med, 1999, 44(8): 713-8.
  • 8Blankstein J, Shalev J, Saadon T, et al. Ovarian hyperstimu- lation syndrome: prediction by number and size ofpreovu- latory ovarian follicles. Fertil Steril, 1987, 47(4):597-602.
  • 9Asch RH, Li HP, Balmaceda JP, et al. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod, 1991, 6(10):1395-9.
  • 10Vloeberghs V, Peeraer K, Pexsters A, et al. Ovarian hyper- stimulation syndrome and complications of ART. Best Pract Res Clin Obstet Gynaecol, 2009, 23(5):691-709.

共引文献19

同被引文献77

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部